(PEMF) in treatment resistant depression. A pilot study
Recommend Documents
... Disorders Program, CAMH, Department of Psychiatry, University of Toronto; ... Centrefor Addiction and Mental Health, 250 College St., Toronto ON MST I R8; ...
Treatment-resistant depression (TRD) is a common clinical problem, often complicated with suicidal ideations and greater lifetime functional impairment, and ...
Treatment strategies for treatment resistant depression (TRD) seek to overcome insufficient responses to monoaminergic antidepressants. Many of the currently ...
Jun 28, 2007 - Benjamin Adam Samuels a,b, Eduardo David Leonardo a, Reto Gadient c, ..... Garcia, L.S., Comim, C.M., Valvassori, S.S., Reus, G.Z., Stertz, L., ...
ORIGINAL PAPER. Neuromodulation for Treatment Resistant Depression: State ... therapy, electroconvulsive therapy) and new interventions in research (e.g. ...
Jul 22, 2014 - depressive disorder (Mdd). however, its clinical utility as an augmenting strategy for treatment-resistant depression (Trd) remains unexplored.
Jul 22, 2011 - Biome`dica Sant Pau (IIB-Sant Pau), Universitat Auto`noma de Barcelona (UAB), Sant Antoni Ma. ... surgery, response and remission (HAMD f7) rates were, respectively 87.5% and 50%. ... Email: [email protected].
Abstract: Electroconvulsive therapy (ECT) and antidepressant are the effective treatment alternatives for patients with treatment-resistant depression (TRD); ...
Ropinirole is a nonergoline dopamine D2âD3 receptor ago- nist indicated for treating Parkinson's disease. The drug is inactivated by cytochrome P450 ...
Abstract. Depression and anxiety affect up to 50% of people with Parkinson's Disease (PD) (Marsh, 2000; Murray, 1996), however, few studies have examined ...
cognitive behaviour therapy (CBT) in treating depression and anxiety in PD. Four participants, aged between 56 and 81 years, who had been diagnosed with PD ...
Abstract: Background: At least 10-20% of the patients suffering from depression meet criteria for treatment-resistant depression (TRD). In the last decades, ...
personality disorders are less responsive to antidepressant therapy compared to patients with no Axis II pathology and have a worse prognosis for long-term ...
public health impact of treatment-resistant depression, a. Paul E. Holtzheimer III, M.D.. Helen S. Mayberg, M.D.. Deep Brain Stimulation for. Treatment-Resistant ...
Suppes TM, Rush AJ, Keck PE, McElroy SL, Luckenbaugh DA, Pol- lio C, Kupka M, Nolen WA: Morbidity in 258 bipolar outpatients followed for 1 year with daily ...
Jan 1, 2013 ... stimulation (TMS) for treatment-resistant depression ... 2013 Cusin and
Dougherty; licensee BioMed Central Ltd. This is an Open Access article ...
Louis, Missouri 63108. Telephone: ..... Lesperance F, Frasure-Smith N, Juneau M, Theroux P. Depression and 1-year prognosis in unstable angina. Arch Intern ...
Page 1. Magnesium for treatment-resistant depression: A review and hypothesis. George A. Eby III *, Karen L. Eby. George Eby Research Institute, 14909-C ...
Background: Patients with treatment-resistant depression (TRD) who showed partial response to pharmacological and psychotherapeutic interventions need a ...
Treatment-Resistant Bipolar Depression: A STEP-BD. Equipoise Randomized Effectiveness Trial of. Antidepressant Augmentation With Lamotrigine, Inositol,.
Oct 18, 2013 - Characterization of Treatment Resistant Depression. Episodes in a Cohort of Patients from a US Commercial. Claims Database.
of treatment-resistant depression (TRD), currently there is no universally accepted definition for TRD. This review summarizes the different meth- ods used to ...
treatment-resistant patients with major depressive disorder. ... All met criteria for treatment-resistant depression (TRD) as they failed four or more trials of medica-.
(PEMF) in treatment resistant depression. A pilot study
OBJECTIVES: Thls pilot study was performed to InvestlKate the applleablilty and po..lble elin Icai effeets nf Pulsed-Eleetro-MaKnetle-Flelds (PEMF) In patients.
OBJECTIVES: Thls pilot study was performed to InvestlKate the applleablilty and po..lble elin Icai effeets nf Pulsed-Eleetro-MaKnetle-Flelds (PEMF) In patients wllh treatment reslstaut depr...lnn. MA TERIAL and METHODS: Eleven patients sufferluK frnm treatment reslstant depre..lou partlclpated In the trlal. They were Informed that the PEMF treatment was uperlmental and that no serlous side effeets has been deserlbed from the use of PEMF In other elin Icai areas (PEMF treatment nf arthroslsln neek, splne, larKe joints and bone heallnK). Patients wllh Intra eranlal meta11mplants or Implanted eleetronle devlees were excluded. DuratIon of treatment was planned to last 5 weeks. Depre..lon ratlnK and elin Icai a ment was done at start olstudy.
F~.., ,;.w
Tbe COt .1s werepIaced m . tbe till o owmg . way
of PEMF treatment (baseUne) and weekly untll end
h ~
The Major Depre..lon Inventory (MDI) was u&ed to measure the severlty of depr...lon throuKhout the study. ChanKe In MDI at baseUne and end of study wal
